Company
Protembis
Protection from Large Brain Lesions and Stroke in TAVR
Also known as Protembis GmbH
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Aachen, Germany
- Founded
- 2013
- Legal name
- Protembis GmbH
Claim, correct or request removal
Record updated 28 September 2026
About
Protembis was founded in 2013 and is headquartered in Aachen, Germany. The company develops innovative technologies to reduce the risk of new significant brain lesions and stroke during cardiology procedures particularly in connection with transcatheter aortic valve replacement (TAVR).
Funding snapshot
- Total raised
- $10MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Undisclosed2024-07-30
Funding rounds
- Protembis receives €20 million backing from the European In…
- 2024-07-30
- Protembis Completes €30M Financing
- 2024-03-26
- Series A
- $10M2018-10-18, Company stated
Products
- Hardware
- ProtEmbo Cerebral Protection System
Loading relationship preview